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ABSTRACT 
 
The present study was carried out to investigate the hepato-protective 
activity of the methanolic extract of Nigella sativa on albino Wister rats.  
Twenty five rats were divided into 5 groups, 5 each; A, B, C were 
saved as control groups, received paraffin, dimethylsulfoxide, CCl4  in 
paraffin respectively; while group D and E received CCl4  in paraffin and  
methnolic extract of Nigella sativa at dose of  250mg/kg body weight and 
500mg/kg body weight respectively.   
There were an increase in the body weights of control groups    (A, B) 
at a rate of 2.0%. However the body weights in group C, D and E were 
reduced by 10.3, 9.3 and 10.3% respectively. The relative organ weights 
ratio showed no significant differences among all groups. There were no 
significantly differences among the groups in WBS, RBC, PCV, MCV, 
MCH and MCHC values, but Hb recorded reduction on day 10 in group D.  
   The results revealed there was no effect on total bilirubin 
concentration between the groups except in group C where total bilirubin 
values raised from 0.2 to 0.7 on day 10, compared to group E which raised 
 xi 
from 0.1 to 0.4. There were significant increased (P>0.05) in ALT, AST and 
ALP activities on day 5 and 10 in group C, D and E compared to control 
groups A and B, but the groups (D and E) which were given both CCl4 and 
N. sativa methanolic extract showed significant inhibition (P>0.05) of 
increased plasma levels (ALT and ALP) compared to the group which given 
only CCl4. However significant reduction (P>0.05) in AST activity was 
observed on day 10 in group E compared to the control group C. 
The livers of control groups were normal, but rats which received 
CCl4 showed central hepatic fatty vaculation and congestion, but in the 
group of rats received 250 and 500 mg/kg body weight of methanolic 
extract, the changes were to a lesser extent.  
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INTRDUCTION 
 
 
Interest in medicinal plants has increased in recent years. The   
Medicinal plants constitute the base of health care system in many 
societies. Among these plants, black seed is a plant used widely in 
traditional medicine by many Asian, Middle Eastern and Far Eastern 
countries for treatment of headache, coughs, asthma, hypertension, 
diabetes, inflammation, bronchitis, eczema, fever, dizziness and 
influenza, also the seeds or its oil are used as a carminative, diuretic, 
lactagogue, and vermifuge, beside been used in food as a spice and a 
condiment (Lautenbacher, 1997).  
 Traditionally the actual importance of Nigella sativa to the 
Muslims came from the holy saying of the prophet Mohammed 
“prayers and peace be upon him”: in the black seed is the medicine for 
every disease except death (Atta-ur-Rahman et al., 1985b). In the 
bible, Nigella sativa is also identified as ‘curative black cumin’, and is 
also described as the Melanthion of Hippocrates and Discroides and as 
the Gith of Pliny (Worthen et al., 1998). 
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Many studies were carried out on back seeds or its oil to insure 
its’ treatment and prevention of diseases, but few were done with 
regard to liver damage especially that liver diseases became  serious 
problems. The aim of this study is to find out whether Nigella sativa 
seeds have hepatoprotective effect in Wister albino rats treated with 
carbon tetrachloride.                
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CHAPTER ONE 
 
LITERATURE REVIEW 
 
          Nigella sativa Linn. (Family Ranunculaceae), commonly known 
as black seed or black cumin, is an annual plant that has been tradi-
tionally used in the Indian subcontinent (Nadkarni, 1976), Arabian 
countries (Sayed, 1980) and Europe (Lautenbacher, 1997) for culinary 
and medicinal purposes. The black, angular seeds, in Arbia known as 
‘Habba Sauda’, ‘Habbet el Baraka’, ‘Kamun-aswad’ and ‘Shunez’ 
(Houghton et al., 1995), (Fig. A and B). 
1.1 Nigella sativa constituents:                       
       Lauteubucher (1997)  found that Nigella sativa seeds contains 36 
- 38% fixed oils, proteins, alkaloids, saponins and 0.4 - 2.5% essential 
oils. Houghton et al. (1995) detected that the fixed   oils are composed 
mainly of unsaturated fatty acids, including the unusual arachidonic 
and eicosadienoic acids. Many components were characterized by 
Burits and Bucar (2000), the major one is thymo-quinone (Fig. C.1). 
           Four alkaloids have been isolated as constituents of the seeds. 
Two namely, nigellicine (Fig. C.2) (Atta-ur-Rahman et al., 1985b) and 
nigellidine  (Fig. C.3)  (Atta-ur-Rahman et al., 1995) having an 
indazole  nucleus. Other two alkaloids are nigellimine (Fig. C.4) 
 6
(Atta-ur-Rahman et al., 1992)   and   its N-oxide   isoquinolines   (Fig. 
C.5) (Atta-ur-Rahman et al., 1985a).  Swamy   and   Benny (2001) 
recently isolated a monodesmosidic triterpene Saponin, α-hederin 
(Fig. C.6)  from N. sativa seeds. 
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Fig. (A):  Flowered Nigella sativa L. plant. 
     
Fig. (B): Nigella sativa L. seeds. 
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Fig. (C): chemical structures of some major constituents of Nigella 
sativa seeds.  
    
1 ≡ thymoquinone, 2 ≡ nigellicine, 3 ≡nigellidine, 4 ≡ nigellimine ,  
5 ≡ Isoquinolines, 6 ≡ α-hederin. 
R in Fig. C (6) ≡αL-Rhman-αL-Ara. 
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1.2 Antioxidant effects:  
           Essential oils of black seeds, N. sativa, were tested for 
antioxidant activity. Burits and Bucar (2000) used a rapid evaluation 
for antioxidants by Thin Layer Chromatography (TLC) screening 
methods. They found that thymoquinone and the components 
carvacrol, t-anethole and 4-terpineol demonstrated respectable radical 
scavenging property. These four constituents and the essential oil 
possessed variable antioxidant activity when tested by the 
diphenylpicrylhydracyl assay for non specific hydrogen atom or 
electron donating activity. They concluded that these constituents 
showed radical scavenging agent in the assay for non-enzymatic lipid 
peroxidation in liposomes and deoxyribose dehydration assay. 
        Turkdogan et al. (2001) investigated the role of antioxidants 
such as vitamin C and E; selenium and N. sativa on the prevention of 
carbon tetrachloride (CCl4) induced liver fibrosis in rabbits. They 
stated that super oxide dismutase (SOD) values were significantly 
lower at 12th week. While glutathione peroxide (GSH) in vitamin C 
treated group were significantly different from the control at 6th and 
12th week of experiment. They pointed out that N. sativa might be 
successful in the prevention of liver fibrosis in rabbits as indicated by 
histopathological findings. 
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          Teschke et al. (1984) have studied the effect of the administra-
tion of the ethanol on carbon tetrachloride (CCl4) and hepatotoxicity in 
rats intragastric or intraperitoneal. They found that three hours after 
acute CCl4 intoxication there was striking increase in CCl4 
concentration in animals treated simultaneously with ethanol intra-
gastrically compared to those receiving ethanol intraperitoneally. 
Serum activities of glutamate oxaloacetate transaminase, glutamate 
pyruvate transaminase and glutamate dehydrogenase were found to be 
considerably higher in animals treated with the combination of CCl4 
and ethanol when compared to these receiving CCl4 alone. 
          Nagi et al. (1999) suggested that the in vivo protective action of 
thymoquinone against CCl4 induced hepatotoxicity may be mediated 
through the combined antioxidant properties of thymoquinone and its 
metabolite dihydrothymoquinone (DHTQ). They stated that a single 
oral dose of thymoquinone resulted in significant protection against 
the hepatotoxic effect of CCl4 and it appeared that thymoquinone was  
reduction to dihydrothymoquinone. They also stated that 
thymoquinone and (DHTQ) inhibited the in vitro non enzymatic lipid 
peroxidation in liver homogenate, and that (DHTQ) was more potent 
in comparison with thymoquinone and butylated hydroxytoluene 
(BHT). 
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      Al-Gamdi (2003) has investigated the effect of the aqueous 
suspension of N. sativa on carbon tetrachloride induced liver damage. 
In this study, the aqueous suspension of the seeds was given orally at 
dose levels of 250 mg/kg body weight   and 500 mg/kg  body weight 
for five days. CCl4 (250 micro l /kg intraperitoeally /day in olive oil) 
was given to the experimental group on days 4 and 5, while the 
control group was only treated with the vehicles. Biochemical changes 
were not evident following administration of   N. sativa alone. Serum 
levels of aspartic transaminase (AST), and L-alanine aminotransferase 
(ALT) were slightly decreased while Lactate dehydrogenase (LDH) 
was significantly increased in animals treated with CCL4 when 
compared to the control group. LDH was restored to normal but ALT 
and AST levels were increased in animals pretreated with N. sativa. It 
was concluded that N. sativa seeds appeared to be safe and possibly 
protective against CCl4-induced hepatotoxicity. 
        Thymoquinone and silybin, a known hepatoprotective agent, 
were tested in isolated rat hepatocytes against tert-butyl hydroperoxide 
(TBHP) toxicity (Daba and Abdel-Rahman, 1998). They found that 
the degree of protection of thymoquinone was less than that caused by 
silybin. 
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1.3 Uses of Nigella sativa: 
          Meral et al. (2001) found that Nigella sativa might be used in 
diabetic patients to prevent lipid peroxidation, increase anti-oxidant 
and defense system activity and prevent liver damage. 
         Pharmacological and toxicological properties of Nigella sativa 
were investigated by Ali and Blunden (2003). They found that the 
pharmacological action of the crude extracts of the seeds caused 
protection against nephrotoxicity and hepatotoxicity induced by either 
disease or chemicals. They stated that the seeds were characterized by 
a very low degree of toxicity. 
       Mahmoud et al. (2002) studied the effect of Nigella sativa oil 
against the liver damage induced by Shistosoma mansoni infection in 
mice. It has been reported that Nigella sativa oil possesses anticestode 
and antinematode actions. Besides, it produced a hepatoprotective 
effect by improving the immunological host system and to some 
extent by its antioxidant effect. 
        Kalus et al. (2003) studied the effect of Nigella sativa on 
subjective feeling in patients with allergic diseases. 152 patients were 
treated with Nigella sativa oil in capsules. The score of subjective 
feeling decreased over the course of treatment with black seed oil. A 
slight decrease in plasma triglycerides and a discrete in HDL 
 13
cholesterol occurred while the lymphocyte subpopulation, endogenous 
cortisol levels and ACTH released remained unchanged. 
        The anticonvulsant activity of thymoquinone, the major 
constituent of Nigella sativa seeds, was reported using pentylene-
tetrazole (PTZ) and maximal electroshock (MES) induced seizure 
models (Hossein and Parvardeh, 2004). 
               Boskabady et al. (2004) reported that Nigella sativa has 
relaxant effect through the inhibitory effect on the calcium channel. 
         In a recent study Kanter et al. (2004) have evaluated the 
possible protective effects of Nigella sativa against beta-cell damage 
from streptozotocin (STZ)-induced diabetes in rats. They found that 
Nigella sativa treatment exerts a therapeutic protective effect in 
diabetic animals by decreasing oxidative stress and preserving 
pancreatic beta-cell integrity. Consequently the authors mentioned that 
Nigella sativa might be clinically useful for protecting beta-cells 
against oxidative stress. 
 
1.4 Haemobiotic effects of Nigella sativa:  
       Meral and Kanter (2003) investigated the effects of N. sativa, 
or/and Urtica dioica on hematological values besides serum Na, K, Cl 
and Ca levels on CCl4-treated rats. They claimed that N. sativa or 
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Urtica dioica treatments alone or in combination can induced 
increased the reduced RBC, WBC, PVC, and Hb levels and also 
significant decreased in the elevated serum K and Ca levels, hence N. 
sativa or/and Urtica dioica treatment might  ameliorate the CCl4 
induced disturbances of anemia. 
     The effect of Nigella sativa on blood hemostatic function in rats 
was studied by Al Jishi and Abou-Hozaifa (2003). They found that 
Nigella sativa induced transient changes in the coagulation activity of 
rats.                  
1.5 Hepatoprotection of Nigella sativa:  
            El-Dakhakhny et al. (2000) showed that daily administration 
of the N. sativa oil per se at a rate of 800mg/kg body weight      orally 
for 4 weeks did not adversely affect the serum transaminase (ALT and 
AST), alkaline phosphate, serum bilirubin or prothrombin activity in 
normal albino rats; however, when the oil was given for  4 weeks prior 
to induction of hepatotoxicity by D-galactosamine or carbon 
tetrachloride, complete protection against D-galactosamine and partial 
protection against carbon tetrachloride hepatotoxicity was evident. 
Also the administration of the oil at a rate 800 mg/ kg body weight 
orally four 4 weeks caused  significant diverse effects on serum total 
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cholesterol, low density lipoprotein, triglycerides and a significant 
elevation of serum high density lipoprotein level.  
           In a study done by Mansour et al. (2001) to evaluate the effects     
of the volatile oil constituents of N. sativa, namely, thymoquinone,    
p-cymene and alpha-pinene in mice treated with carbon tetrachloride, 
revealed that a single dose of CCl4 at a rate of 15 micro l /kg body 
weight intraperitoneally induced hepatotoxicity 24 hours after 
administration. However, administration of different doses of 
thymoquinone did not have any effect in liver function tests while 
higher doses were lethal. Pretreatment of mice with different doses of 
thymoquinone one hour before CCl4 injection showed that 12.5 mg/kg 
body weight   of thymoquinone given intraperitoneal was the only dose 
that ameliorated hepatotoxicity of CCl4. They concluded that 
thymoquinone at a rate of 12.5 mg/ kg body weight   may play an 
important role as antioxidant and may efficiently acts as a protective 
agent against chemically induced hepatic damage. However, higher 
doses of thymoquinone were found to induce oxidative stress leading 
to hepatic injury. Nevertheless, treatment of mice with the other 
volatile oil constituents, p-cymene or α-pinene, did not induce any 
changes in liver enzymes. 
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CHAPTER TWO 
                             MATERIALS AND METHODS 
2.1 Materials and Experimental Design: 
2.1.1 Animals: 
         Twenty five healthy adult Wister albino rats of both sex, 
weighing 120.3 – 285.3 g, were used. They were kept in cages within 
the Department of Biochemistry, Faculty of Veterinary Medicine, 
University of Khartoum. They were housed in standard environmental 
conditions with free access to feed and water. They were kept for 7 
days, as an adaptation period.   
2.1.2 Plant:  
              Nigella sativa seeds were brought from the local market at 
Omdurman and purified. The plant was extracted in the phyto-
chemistry laboratory at Medicinal and Aromatic Plants Research 
Institute (MAPRI), Khartoum.  
2.1.3 Experimental design:                                                                      
         At the end of the adaptation period the rats were divided 
randomly into 5 groups A, B, C, D and E; of 5 rats each. The animals 
were treated daily for 10 days. Group A, B, C saved as controls; while 
groups D and E are the treated groups. 
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Group A was received 0.2 ml/kg body weight liquid paraffin 
i/p. Group B  received dimethyl sulfoxide (DMS) 0.2 ml/kg body 
weight i/p. Group C was injected i/p with CCl4 at a dose rate of 
0.2ml/kg body weight in liquid paraffin (1: 9). Group D and E were 
injected with CCl4 in paraffin as in group C together with 250 mg/kg 
body weight and 500 mg/kg body weight of the Nigella sativa 
methanolic extract orally respectively.  
2.1.4 Parameters:  
           Clinical signs and mortality were recorded. Blood samples 
were obtained by puncturing retro orbital plexus into dry clean tubes 
and allowed to clot at room temperature (waynforth, 1980) or at 
slaughter time for analysis. The sera were separated by centrifugation 
at 3000 r.p.m for 5 minutes in Hettich EBA 35 centrifuge and stored at 
-20oC until analyzed for biochemical tests. Blood samples for 
hematological analysis were collected in EDETA containers.    
       Sera were analyzed for the activities of alkaline phosphatase 
(ALP), alanine amino transferase (ALT)/(GPT), aspartate amino 
transferase (AST)/(GOT) and for the bilirubin concentration. 
The EDETA blood was examined for white blood cells (WBC), 
red blood cells (RBC) counts, hemoglobin (Hb) concentration and 
packed cell volume (PCV). Also mean corpuscular volume (MCV), 
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mean corpuscular hemoglobin (MCH) and mean corpuscular 
hemoglobin concentration (MCHC) were calculated. 
Specimens of liver, heart, kidney, spleen and brain were 
collected immediately after slaughter and were fixed in 10% formalin 
for histopathology. 
2.2 Methods: 
2.2.1 Plant extract: 
                Nigella sativa seeds were dried and extracted according to 
Harborne method (1976). 70g of granulated seeds were inserted in 
soxhlet apparatus (Quick Fit, Ex 5183). The oil have been separated 
using 100 ml of petroleum ether (40-60%) overnight. The sample was 
unpacked and left to dry, then repacked again with adding methanol 
(99.9%) as a solvent to get the polar constituents of the plant. The 
extract was evaporated till dryness using a rotavapor.  
 Carbon tetrachloride (CCl4) solution was prepared by adding 
CCl4 to paraffin oil at a ratio of 1:9 respectively.                                                             
2.2.2 Biochemical methods: 
       Sera constituents were determined using Roche Diagnostics/ 
Hitachi 902 Analyzer; Fig. (D). It was fully automated, computerized 
and performs potentiometric and photometric assays. It  has  an  on-
board capacity  of  26  tests  throughput  of  up  to  200  tests  per  
 20
hour  and  up  to  300  tests  with  optional  ISE  unit.   
2.2.2.1 Alkaline Phosphatase (ALP): 
      The activity of ALP was measured by an optimized standard 
method according to recommendation of Chemie (1972). 
Principle:  
     Alkaline phosphatase in alkaline medium splits p-nitrophenyl 
phosphate in the presence of Mg2+ ions, into p-nitrophenol and 
phosphate. 
  p-nitrophenyl phosphate + H2O   ALP      phosphate + p-nitropheonol           
       ALP (I/U) =        A405 nm/min x 2760  
            A ≡   the mean sample absorbance reading. 
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              Fig. (D): Hitachi 902 automated Analyzer 
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2.2.2.2 Alanine amino transferase (ALT), Glutamic pyruvic transa-
minase (GPT): 
      Glutamic pyruvic transaminase (GPT) was measured by enzymatic 
method according to the method of   Reitman and Frankel (1957). 
Alanine amino transferase was measured by monitoring the 
concentration of pyruvate hydrazone formed with 2,4-dinitrophenyl- 
hydrazine. 
Principle: 
α-oxoglutarate + L-alanine    GPT     L-glutamate + pyruvate. 
 The GPT was measured in I/U 
2.2.2.3 Aspartate amino transferase (AST), Glutamate oxalo-
acetate transaminase (GOT):  
       Glutamic oxaloacetate (GOT) in sera was measured by 
enzymatic method according to the method of Reitman and Frankel 
(1957). Aspartate amino transferase was measured by monitoring the 
concentration of oxaloacetate hydrazone formed with 2,4- 
dinitrophenyl hydrazine. 
Principle: 
      α-oxoglutarate + L-aspartate      GOT     L-glutamate + oxaloacetate. 
         AST was measured in I/U. 
2.2.2.4 Total Bilirubin:  
          Total bilirubin reacts with diazotized dichloroaniline to form a 
colored azo compound according to the method of Jendrassik and 
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Grof (1938). The intensity of the color was proportional to the 
bilirubin concentration in the sample.    
              Total bilirubin (mg/dl) =   total absorbance x 17.5  
2.2.3 Hematological methods: 
The analysis of blood samples were done by “Sysmex 
automated hematology analyzer KX-21.” Fig. (E). 
The sysmex KX-21 is an automatic multi parameter blood cell 
counter for in vitro diagnostic use in clinical laboratories. The KX-21 
employs three detector blocks to the kind of reagents for blood 
analysis. The WBC count was measured by the WBC detector block 
using the DC detection method. The RBC count and platelets were 
measured by the RBC detector block using the DC detecting method. 
The Hb detector block measured the hemoglobin concentration using 
the non cyanide hemoglobin method. 
Blood was aspirated from the sample probe into the sample 
rotor valve. 6 µL of blood measured by the sample rotor valve were 
transferred to the WBC transducer chamber along with 1.994 ml of 
diluents. At the same time 0.1 ml of WBC/Hb lyse was added to 
prepare 1:500 dilution sample. 
When the solution was made in approximately 10 seconds, RBC 
were hemolyzed and platelets shrink, with WBC membrane held as 
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they are. At the same time hemoglobin is converted into red colored 
met hemoglobin. Of the diluted/hemolyzed sample in the WBC 
transducer chamber, approximately 1 ml was transferred to the Hb 
flow cell. 
500 µL of sample in the WBC transducer were aspirated 
through the aperture. The pulses of the blood cells when passed 
through the aperture are counted by the DC detecting method. 
In the Hb flow cell, 555 nm wavelength beam irradiated from 
the light emitting diode (LED) was applied to the sample in the Hb 
flow cell. Concentration of the diluents alone was measured before 
addition of the sample; hence Hb (hemoglobin value) was calculated.  
         PCV evaluation by the analysis principles that RBC pulse height 
detection method ratio (%) of whole RBC volume in whole blood.   
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Fig. (E): Sysmex automated hematology analyzer KX-21. 
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Mean corpuscular volume (MCV):   
          Mean corpuscular volume in whole blood was calculated from 
RBC and PCV values as follows:  
                               MCV = PCV x 10/ RBC x 106   (fl) 
Mean corpuscular hemoglobin (MCH):          
            Mean hemoglobin volume (pg) per RBC was calculated from 
Hb and RBC as follows: 
HGB x 10  MCH (pg) = RBC 
Mean corpuscular hemoglobin concentration (MCHC): 
      Mean corpuscular hemoglobin concentration (g/dl), was calculated 
from Hb and PCV as follows:                               
HGB (g/dl) x 10   MCHC (g/dl) = PCV 
2.2.4 Histopathology:  
          The specimens of tissues were collected immediately after 
dissection of animals, fixed in 10% buffered formalin, embedded in 
paraffin wax, sectioned at 5 µm and stained with haematoxylin and 
eosin; according to the method of Drury and Wallington (1980). 
2.2.5. Statistical analysis:   
1. Data were analyzed for significance using completely 
randomized design. General Linear Models (GLM) 
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procedure of SAS (1998) software was used to run the 
data analysis with each test being at 0.05% level of 
probability by Duncan multiple range tests. Body weights 
and organ body weight ratio were compared using t-test 
procedure according to Mendenhall (1971). 
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CHAPTER THREE 
RESULTS 
3.1 Clinical signs: 
 There were no clinical signs observed in rats of all groups, 
however in group D which received 250 mg/kg body weight of 
Nigella sativa methanolic extract, there were two rats looked dull after 
five days following treatment. 
3.2 Body weights: 
 The body weights were presented in Table (1). There was an 
increase in the body weights of the control groups (A, B) at a rate of 
2.0%. However, the body weights in group C, D and E were reduced 
by 10.3, 9.3 and 10.3% respectively. The reduction was significant in 
group E (500 mg/kg Nigella sativa methanolic extract) compared to 
the control group C (CCl4). 
3.2.1 Organs to body weight ratio: 
 Table (2) showed that there were no significant changes in the 
relative liver and kidney weights among all groups.  
3.3 Hematological findings: 
 The hematological values in albino rats that received Nigella 
sativa extract compared to the controls were summarized in Table (3). 
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Table (1): Body weights of albino rats given methanolic extract of 
Nigella sativa. 
  
                       Body weights (g) 
Groups 
Day  0 Day 10 
A  247.5 ± 26.6a 252.2 ± 26.4 a 
B  227.6 ± 47.9 a 232.1 ± 44.8 a 
C  174.7 ± 27.6 a 156.8 ± 19.11 a 
D  156.3 ± 19.3 a 141.7 ± 22.4 a 
E  128.7 ± 10.7 a 115.5 ± 4.9 a 
 
 
 
Table (2): Relative Organs weight ratio of albino rats given 
methanolic extract of Nigella sativa. 
  
Relative organ weights (%) 
Group 
Liver Kidney 
A 2.6 ± 0.1 a 0.4 ± 0.1 a  
B 2.7 ± 0.3 a  0.3 ± 0.0 a 
C 3.1 ± 0.3 a  0.4 ± 0.0 a 
D 4.5 ± 0.5 a 0.4 ± 0.0 a 
E 3.7 ± 0.3 a 0.4 ± 0.1 a  
 
Means (± SD) within the same column having the same superscript letters are not 
significantly different at (P>0.05) based on t-test. 
Group A ≡ received liquid paraffin.    
Group B ≡ received dimethylsullfoxide.  
Group C ≡ received CCl4 in paraffin.   
Group D ≡ received CCl4+250 mg/kg Bwt. methanolic extract of Nigella sativa.  
Group E ≡ received CCl4 +500 mg/kg Bwt. methanolic extract of Nigella sativa. 
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3.3.1 WBC and RBC: 
 There were no significant difference between the treated and the 
control groups on day 5 and 10 for both WBC and RBC. 
3.3.2 Hemoglobin: 
  Hemoglobin values showed no significant difference between 
controls and treated rats except for a reduction in group D which 
received 250 mg/kg Nigella sativa methanolic extract at   day 10.  
3.3.3 PCV: 
   There were no significant differences of PCV values through-
out the experimental period between treated and the control groups.   
3.3.4 MCV: 
        MCV showed no significant differences throughout experimental 
period between treated groups compared to the control. 
3.3.5 MCH and MCHC: 
 There were no significant differences recorded for MCH or 
MCHC values in the treated groups compared to the control groups. 
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Table (3): Effect of Nigella sativa methanolic extract on hematological values of Wister albino rats intoxicated       
with CCl4: 
 
Days Groups WBC (103/µl) 
RBC 
(106/µl) 
Hb 
(g/dl) 
PCV 
(%) 
MCV 
(fl) 
MCH 
(pg) 
MCHC 
(g/dl) 
A 5.3 ± 1.3a 7.5 ± 0.4a 14.1 ± 0.6a 44.0 ± 2.4a 59.0 ± 2.0a 18.9 ± 0.9b 32.1 ± 1.4b 
B 7.9 ± 2.6a  6.6 ± 0.9a 13.1 ± 1.2a 40. ± 7.4a 60.1 ± 4.2a 20.0 ± 2.4b 33.5 ± 5.8b 
C 6.4 ± 2.8a 7.1 ± 0.8a 14.0 ± 0.8a 42.6 ± 5.4a 59.8 ± 3.5a 19.8 ± 1.7b 33.3 ± 3.7b 
D 8.0 ± 3.9a 7.3 ± 0.2a 14.5 ± 0.7a 45.5 ± 2.2a 62.4 ± 2.3a 19.9 ± 0.9b 31.9 ± 1.8b 
Zero 
E 5.2 ± 1.9a 5.5 ± 1.0b 12.4 ± 1.2a 32.7 ± 6.8a 59.7 ± 2.7a 23.3 ± 2.9a 39.2 ± 5.8a 
A 13.9 ± 1.9a 7.2 ± 0.8a 14.4 ± 1.1a 47.5 ± 3.7a 66.4 ± 3.8a 20.2 ± 1.3a 30.5 ± 2.0a 
B 11.8 ± 2.9a 6.7 ± 0.5a 13.7 ± 0.7a 43.4 ± 4.8a 65.1 ± 3.5a 20.6 ± 0.6a 31.7 ± 2.2a 
C 7.9 ± 3.2a  6.4 ± 1.2a 12.5 ± 1.0a 40.4 ± 8.8a 62.7 ± 3.9a 20.3 ± 4.2a 28.6 ± 2.2a 
D 12.9 ± 3.5a 5.7 ± 1.5a 10.1 ± 2.5b 38.5 ± 11.9a 62.5 ± 0.6a 17.7 ± 1.1a 26.8 ± 2.1a 
10 
E 12.9 ± 3.9a 6.7 ± 0.5a 12.8 ± 0.5a 42.4 ± 4.4a 63.6 ± 4.9a 19.3 ± 0.8a 30.6 ± 3.1a 
.  
                   Means (±SD) within the same column having the same superscript letters are not significantly different at (P>0.05) level based on SAS software method.  
Group A ≡ received liquid paraffin.    
Group B ≡ received dimethylsullfoxide.  
Group C ≡ received CCl4 in paraffin.   
Group D ≡ received CCl4 +250 mg/kg methanolic extract of Nigella sativa.  
Group E ≡ received CCl4 +500 mg/kg methanolic extract of Nigella sativa. 
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3.4 Changes in serum constituents: 
 The effects of methenolic extract of Nigella sativa on the activities of 
serum ALT, AST and ALP and the concentration of total bilirubin were 
given in Table (4). 
3.4.1 Total bilirubin:  
 There were no significant differences in the total bilirubin 
concentration between the groups throughout the experimental period. 
However in group C, (received CCl4), total bilirubin values were raised 
from0.2 to 0.7 on day 10, compared to group received 500 mg/kg body 
weight  Nigella sativa methanolic extract from 0.1 to 0.4, which showed 
slight increase in this group compared to C (CCl4) group. 
3.4.2 ALT: 
The activity of ALT showed significant increase (P> 0.05) on day 5 
and 10 in groups; C (CCl4), D (250 mg/kg body weight) and E (500 mg/kg 
body weight) of Nigella sativa methanolic extract compared to the control 
groups A and B. On the other hand group E remarked significant decrease 
(P> 0.05) compared to group C (CCl4) on day 5 and 10. However significant 
decrease (P> 0.05) was observed in group D (250 mg/kg body weight 
Nigella sativa methanolic extract) on day 10 compared to group C (CCl4).  
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3.4.3 AST: 
 The AST activity was significantly increased on day 5 and day 10 (P> 
0.05) in the groups of rats which received CCl4, 250 mg/kg and 500 mg/kg 
body weight  of Nigella sativa methanolic extract compared to the control 
groups A and B. On the other hand significant decrease (P> 0.05) in group D 
and E on day 5 and significant decrease (P> 0.05) in group E on day 10 were 
observed when compared them to the group C (CCl4).   
3.4.4 ALP: 
 Compared to the control groups A and B, the activity of ALP showed 
no significant difference in group D (250 mg/kg body weight Nigella sativa 
methanolic extract, but significant increase (P> 0.05) was recorded in group 
C and E on day 5 and 10. However significant reduction was recorded on 
day 5 and 10 in group D compared to CCl4 group.  
3.5 Histopathological findings: 
 In the control groups (those received paraffin and dimethyl-sulfoxide, 
their livers were normal (Fig. F), so rats received CCl4 showed central 
hepatic fatty vaculation and congestion (Fig. G). In the group of rats 
received 250 and 500 mg of the methanolic extract, there were vaculation 
around the central vein but to a lesser extent (Fig. H and I).  
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Table (4): Effect of Nigella sativa methanolic extract on some 
biochemical parameters of Wister albino rats intoxicated with 
CCl4: 
 
Days Groups 
Total 
bilirubin 
(mg/dl) 
ALT 
(U/L) 
AST 
(U/L) 
ALP 
(U/L) 
Zero A 0.2 ± 0.02c 48.6 ± 9.8a 107.2 ± 6.3a 167 ± 31.2b 
 iv
B 0.2 ± 0.02c 47.0 ± 14.1a 119.0 ± 22.4a 133.8 ± 33.7b 
C 0.2 ± 0.03c 39.2 ± 7.1a 103.2 ± 18.7a 75.8 ± 13.3b 
D 0.1 ± 0.02c 40.0 ± 14.8a 93.8 ± 11.9a 153.0 ± 100.6b 
E 0.1 ± 0.03c 51.3 ± 15.8a 97.0 ± 9.9a 302.8 ± 99.6a 
A 0.3 ± 0.03c 69.6 ± 10.6c 152.2 ± 19.1c 167.1 ± 50.0c  
B 0.1 ± 0.04c 58.0 ± 9.7c 163.8 ± 24.5c 160.0 ± 55.2c 
C 0.2 ± 0.1c 1185.2  ± 430.4a 1626.8 ± 737.6a 241.2 ± 33.2a 
D 0.2 ± 0.8c 944.0 ± 455.5a  896.8 ± 403.5b  142.8 ± 65.5c 
Day 5 
E 0.1 ± 0.03c 581.3 ± 348.6b 713.8 ± 187.2b 224.0 ± 12.8a 
A 0.1 ± 0.02c 85.4 ± 9.6 c 177.8 ± 17.8c 167.0 ± 21.8c 
B 0.2 ± 0.01c 59.4 ± 11.0c 176.6 ± 21.5c 129.2 ± 24.8c 
C 0.7 ± 0.8c 1160.3 ± 141.1a 1961.0 ± 311.3a 453.5 ± 176.5a 
D 0.6 ± 0.3c 810.6 ± 246.2b  1425.4 ± 732.4a 298.0 ± 65.4b  
Day 
10 
E 0.4 ± 0.2c 572.0 ± 283.6b 849.8 ± 262.5b 293.5 ± 130.5b 
 
                   Means (±SD) within the same column having different small superscript letters are 
significantly different at (P>0.05) level based on SAS software method.  
Group A ≡ received liquid paraffin.    
Group B ≡ received dimethyl sullfoxide.  
Group C ≡ received CCl4 in paraffin.   
Group D ≡ received 250 mg/kg methanolic extract of Nigella sativa.  
Group E ≡ received 500 mg/kg methanolic extract of Nigella sativa. 
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CHAPTER FOUR 
DISCUSSION 
 The present study deals with the hepatoprotective effect of Nigella 
sativa. In this study body weight gain was lower in rats treated with CCl4 
and Nigella sativa extract. This is in harmony with the findings of Zaoui et 
al. (2002) who showed that there was significant slowdown of   the body 
weight in animals treated with Nigella sativa. 
 viii
 In this study liver damage was induced in rats by the administration of 
CCl4. The mechanism of CCl4 hepatotoxicity is due to the enzymatic 
activation, cytochrome P450, of CCl4 into trichloromethyl free radical 
(•CCl3) within the membrane of the endoplasmic reticulum. This followed by 
chloromethylation and peroxidation leading to functional and structural 
damage (Reckangel, 1967). Thymoquinone, major constituent of Nigella 
sativa, is claimed to be hepatoprotective and its mechanism is due to the 
presentation of intracellular glutathione (EL-Dakhakhny et al., 2000). 
  Meral and Kanter (2003) showed that Nigella sativa induced a 
significant increase for the reduced RBC, WBC,PCV and Hb levels; this is 
in  agreement concerning  Hb values  which increased on day 10 at the dose 
500mg/kg bodyweight of methanolic extract of Nigella sativa but disagree 
with 250mg/kg bodyweight of methanolic extract of Nigella sativa in which 
Hb was reduced. However EL-Sarha et al (1997) reported a significant 
reduction in RBC and PCV in goats which treated with Nigella sativa seeds, 
while WBC showed significant increase. This disagree with our findings, 
may be due to difference in anatomical structure between goats and rats.  
 The present study showed that the values of ALT and AST were 
significantly decreased (P>0.05) in rats that received 500 mg/kg body 
weight Nigella sativa extract on day 5 and 10 compared to the control group 
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C (CCl4). This is in agreement with Daba and Abdel-Rahman (1998) who 
tested thymoquinone in isolated hepatocytes against tert-butyl hydroxide 
(TBHP) induced toxicity evidenced by alteration in ALT and AST. Similar 
results were also found by Nevin and Dilara (2005) who stated significant 
rise in plasma AST and ALT in animals   injected with CCl4 and by 
administration of Nigella sativa showed marked inhibition of increased 
enzyme plasma levels.. Similar results were found by Nevin and Dilara 
(2005) who stated significant rise in plasma AST and ALT in animals   
injected with CCl4 and by administration of Nigella sativa showed marked 
inhibition of increased enzyme plasma levels. Corresponding findings 
recorded by Mansour et al (2001) who stated that thymoquinone at a dose 
rate of 12.5 mg/kg body weight i/p in mice induced significant reduction of 
the elevated serum enzymes levels. However, contravention results were 
recorded by AL- Ghamdi (2003) who investigated the effect of the aqueous 
suspension of Nigella sativa on carbon tetrachloride induced liver damage. 
He found that ALT and AST levels were increased in animals pretreated 
with Nigella sativa compared to CCl4 group. This may suggest that there was 
slight hepatoprotective activity of the methanolic extract of Nigella sativa 
seeds when dosed at a high concentration. 
 x
 EL- Dakhakhny et al. (2000) and Zaoui et al. (2002) found that 
Nigella sativa seed fixed oil induced no change in serum bilirubin level in 
treated rats after 4 and 12 weeks respectively. This is in agreement to the 
present study which showed no significant differences in total bilirubin 
activity. Nigella sativa constituents may be responsible for the 
protective effects against liver damage. 
  Histopathological changes including centrilobular degeneration 
occurred in rats liver that received CCl4 were similar to those described by 
Valcheva et al. (2004) and Ozbek et al. (2004). Nigella sativa extract 
improved the histopathological changes, hence lower the liver damage. This 
protection may be due to partial inhibition of lipid peroxidation. 
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Conclusion 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 The results of this study indicated that the liver damage produced by 
CCl4 was partially inhibited by the methanolic extract of Nigella sativa as 
evidenced by the histopathology and enzymes activity. The high doses of the 
methanolic extract of Nigella sativa may be more effective than low ones. 
Also the methanolic extract reflects less protection than the oil of these 
seeds. Further comparative studies should be carried out to confirm these 
 xii
findings and find out the suitable dose of Nigella sativa that a 
hepatoprotective effect.   
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